Contrasting CymaBay Therapeutics (NASDAQ:CBAY) and Eyenovia (NASDAQ:EYEN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
CymaBay Therapeutics (NASDAQ:CBAY – Free Report) and VYNE Therapeutics (NASDAQ:VYNE – Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and profitability. Analyst Recommendations This is a summary of recent recommendations […]
Published: Feb 23, 2021
PHILADELPHIA (BUSINESS WIRE) Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced that Adam Dinerman, Ph.D. and John Liu, Ph.D. have joined the company as Executive Director, Head of Chemistry, Manufacturing and Controls (CMC) and Vice President, Biology, respectively.
“The addition of top talent with deep functional experience is a critical success driver for Aro as we enter our next phase of growth,” stated Sue Dillon, Ph.D., co-founder and Chief Executive Officer of Aro Biotherapeutics. “We are very excited that Adam and John are joining our company, and are confident that they will both add tremendous value to our organization as our pipeline and platform continue to advance.”